Brian Cheng
Directeur/Membre du Conseil chez JUBILANT FLAME INTERNATIONAL, LTD.
Fortune : 11 400 $ au 30/04/2024
Profil
Brian Cheng is currently the Director at Jubilant Flame International Ltd.
and also holds the position of Chief Technical Officer & Director at Biomark Technologies, Inc. He previously worked as a Manager-Operation Excellent at Mallinckrodt Pharmaceuticals Ltd.
Mr. Cheng has a graduate degree from the University of Washington and an undergraduate degree from Indiana University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/05/2024 | 300 000 ( 1,50% ) | 11 400 $ | 30/04/2024 |
Postes actifs de Brian Cheng
| Sociétés | Poste | Début |
|---|---|---|
| JUBILANT FLAME INTERNATIONAL, LTD. | Directeur/Membre du Conseil | 15/01/2019 |
| Biomark Technologies, Inc. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Brian Cheng
| Sociétés | Poste | Fin |
|---|---|---|
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Corporate Officer/Principal | - |
Formation de Brian Cheng
| Indiana University | Undergraduate Degree |
| University of Washington | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| Jubilant Flame International Ltd. | |
| Biomark Technologies, Inc. | |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Health Technology |